In our study, the high Fn levels of cancer tissue were associated with key tumor molecular features of CRC, including MLH1 methylation, MSI-high, CIMP-high, KRAS mutation, and BRAF mutation, which were associated with clinical outcomes in CRC. The gene discussed is MLH1; the disease is neoplasm.